Hemostemix Historical Balance Sheet
HEM Stock | CAD 0.08 0.01 5.88% |
Trend analysis of Hemostemix balance sheet accounts such as Total Current Liabilities of 2.4 M or Property Plant And Equipment Net of 174 provides information on Hemostemix's total assets, liabilities, and equity, which is the actual value of Hemostemix to its prevalent stockholders. By breaking down trends over time using Hemostemix balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Hemostemix latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hemostemix is a good buy for the upcoming year.
Hemostemix Inventory |
|
Hemostemix |
About Hemostemix Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Hemostemix at a specified time, usually calculated after every quarter, six months, or one year. Hemostemix Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Hemostemix and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Hemostemix currently owns. An asset can also be divided into two categories, current and non-current.
Hemostemix Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Hemostemix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Hemostemix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Hemostemix balance sheet. This account contains Hemostemix investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Hemostemix fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Short Long Term Debt
The total of a company's short-term and long-term borrowings.Most accounts from Hemostemix's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Hemostemix current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemostemix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Hemostemix's Other Current Liabilities is fairly stable compared to the past year. Net Debt is likely to climb to about 4.4 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 2.4 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 1.0M | 2.6M | 3.0M | 3.2M | Total Assets | 563.0K | 465.3K | 313.8K | 298.1K |
Hemostemix balance sheet Correlations
Click cells to compare fundamentals
Hemostemix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hemostemix balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 104.3K | 2.3M | 563.0K | 465.3K | 313.8K | 298.1K | |
Other Current Liab | 2.1M | 3.2M | 1.0M | 2.6M | 3.0M | 3.2M | |
Total Current Liabilities | 4.1M | 3.4M | 4.4M | 2.6M | 2.9M | 2.4M | |
Total Stockholder Equity | (4.0M) | (1.1M) | (5.3M) | (6.8M) | (7.4M) | (7.0M) | |
Net Tangible Assets | 487.8K | (4.0M) | (1.1M) | (6.8M) | (6.1M) | (5.8M) | |
Net Debt | 2.0M | (83.0K) | 1.3M | 4.0M | 4.2M | 4.4M | |
Retained Earnings | (41.5M) | (49.2M) | (55.5M) | (60.8M) | (63.3M) | (60.1M) | |
Accounts Payable | 2.1M | 3.2M | 4.4M | 2.4K | 2.9M | 1.6M | |
Cash | 24.1K | 258.0K | 219.4K | 135.7K | 155.4K | 147.6K | |
Non Current Assets Total | 4.5K | 2.0K | 902.0 | 407.0 | 184.0 | 174.8 | |
Cash And Short Term Investments | 24.1K | 258.0K | 219.4K | 135.7K | 155.4K | 147.6K | |
Net Receivables | 75.8K | 2.1M | 342.7K | 138.9K | 25.1K | 23.8K | |
Common Stock Shares Outstanding | 15.0M | 32.2M | 57.4M | 70.0M | 82.5M | 86.6M | |
Liabilities And Stockholders Equity | 104.3K | 2.3M | 563.0K | 465.3K | 313.8K | 298.1K | |
Inventory | (88.2K) | (13.3K) | (45.5K) | (342.7) | (394.1) | (413.81) | |
Other Current Assets | 13.3K | 45.5K | 342.7 | 190.3K | 133.1K | 101.6K | |
Other Stockholder Equity | 6.0M | 8.7M | 10.1M | 10.2M | 11.9M | 12.5M | |
Total Liab | 4.1M | 3.4M | 5.8M | 7.2M | 7.7M | 8.1M | |
Total Current Assets | 99.8K | 2.3M | 562.1K | 464.9K | 313.6K | 297.9K | |
Accumulated Other Comprehensive Income | 439.7K | 1.5M | 1.5M | 2.7M | 1.5M | 1.5M | |
Net Invested Capital | (2.0M) | (923.7K) | (3.8M) | (2.6M) | (3.0M) | (2.9M) | |
Net Working Capital | (4.0M) | (1.1M) | (3.8M) | (2.2M) | (2.6M) | (2.4M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.